Top compounds associated with response to RNPC3


Feature Type Standardized
Nominal ANOVA
mRNA Irinotecan gCSI pan-cancer AAC -0.026 0.7
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.017 0.7
mRNA AGK-2 CTRPv2 pan-cancer AAC 0.018 0.7
mRNA C6-ceramide CTRPv2 pan-cancer AAC -0.018 0.7
mRNA Cisplatin GDSC1000 pan-cancer AAC -0.017 0.7
mRNA Sorafenib GDSC1000 pan-cancer AAC -0.028 0.7
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC -0.017 0.7
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.016 0.7
mRNA valdecoxib CTRPv2 pan-cancer AAC 0.016 0.7
mRNA isonicotinohydroxamic acid CTRPv2 pan-cancer AAC -0.021 0.7
Download CSV